South Rampart Pharma Receives FDA Fast Track Designation
South Rampart Pharma Receives FDA Fast Track Designation NEW ORLEANS – South Rampart Pharma, a clinical-stage biopharmaceutical company targeting the safer treatment of pain, has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the company for SRP-001 for the treatment of acute pain. SRP-001 is a “non-opioid analgesic … Read more
